The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension - An open-label observational study

PA Sarafidis, AN Lasaridis, Peter Nilsson, TF Mouslech, AD Hitoglou-Makedou, PC Stafylas, KA Kazakos, JG Yovos, AA Tourkantonis

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension - An open-label observational study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science